SSG
MR

Summit Securities Group’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Summit Securities Group’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-200
Closed -$6K – 705
2014
Q1 		$6K Buy
+200
New +$7K ﹤0.01% 305

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Summit Securities Group's MR Position: Q2 2014 in Review

Summit Securities Group sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2014, closing a stake of 200 shares — an estimated $6K sold.

Summit Securities Group first reported a position in MR in Q1 2014 and held it in 1 quarter. The position peaked at $6K in Q1 2014. 131 funds tracked by Wall St. Rank hold MR as of Q2 2014.

  • Summit Securities Group reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q2 2014 after selling out during the quarter.
  • Summit Securities Group sold 200 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q2 2014, an estimated $6K.
  • Summit Securities Group first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q1 2014 and held it in 1 quarter.
  • Summit Securities Group's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $6K in Q1 2014.
  • 131 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2014.

Based on Summit Securities Group's 13F filing for Q2 2014, filed 12 Aug 2014.